Trial Profile

Research for biomarkers of inflammatory bowel disease. - Investigation of the usefulness of LRG for evaluation of disease condition after adalimumab treatments

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 31 Dec 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Adalimumab (Primary)
Indications Crohn's disease; Ulcerative colitis
Focus Biomarker; Pharmacodynamics
Acronyms Planet Study

Most Recent Events

13 Mar 2019 Status changed from active, no longer recruiting to completed.
29 Nov 2018 Planned End Date changed from 4 Nov 2018 to 20 Nov 2018.
29 May 2018 Planned End Date changed from 31 Mar 2019 to 4 Nov 2018.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com